KTP vs CO2 Laser for the Treatment of Laryngeal Carcinoma

Sponsor
Kaplan Medical Center (Other)
Overall Status
Unknown status
CT.gov ID
NCT02672904
Collaborator
(none)
40
1
2
84
0.5

Study Details

Study Description

Brief Summary

comparison results of treatment of early stage glottic cancer between two methods of surgical treatment - CO2 laser and KTP laser

Condition or Disease Intervention/Treatment Phase
  • Device: CO2 laser
  • Device: KTP laser
N/A

Detailed Description

Randomized controlled double-blinded study. The study group includes patients diagnosed with early glottic cancer, either carcinoma in situ or T1a-b,N0M0 squamous cell carcinoma.

Patients will undergo examination and treatment and at least 3 years of follow-up.

40 cancer patients will be included. The participants will be randomly divided into two groups: the first will be treated by KTP laser and the second by CO2 laser.

The patients will be blinded to the method of treatment. To enable double-blinding, the investigator performing the surgery would be the only one knowing which research group the patient belongs to. The investigator in charge of collecting the data after the operation will be blinded to the treatment method.

Each participant will undergo pre-operative evaluation and follow-up after surgery in both arms.

Preoperative evaluation will include:
  • Voice Handicap Index questionnaire

  • GRBAS - subjective assessment of voice quality.

  • Video-stroboscopy of vocal cords

  • Voice Analysis .

Follow-up after surgery:
  • Visit 6 weeks after surgery (± two weeks), and then every three months (± 6 weeks).

  • repeated full evaluation (questionnaire, GRBAS, Stroboscopy, voice analysis) in 30 weeks of follow up and 3 years of follow up.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
40 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Comparison Between the Use of KTP Laser vs. CO2 Laser for Endoscopic Surgical Removal of Malignant Neoplasms of the Vocal Cords
Study Start Date :
Jan 1, 2013
Anticipated Primary Completion Date :
Jan 1, 2019
Anticipated Study Completion Date :
Jan 1, 2020

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: CO2 laser

Patients undergoing endoscopic treatment with CO2 laser

Device: CO2 laser
surgical removal of carcinoma from the vocal cords with CO2 laser

Active Comparator: KTP laser

Patients undergoing endoscopic treatment with KTP laser

Device: KTP laser
surgical removal of carcinoma from the vocal cords with KTP laser

Outcome Measures

Primary Outcome Measures

  1. Duration of surgery [intraoperative]

    total time (minutes) of surgical procedure

  2. number of surgical interventions [3 years]

    total number of surgical interventions needed to eliminate the disease

  3. Recovery time after surgery [up to 3 years]

    recovery in terms of overall function, breathing, swallowing and vocal communication

  4. voice quality results In the short term [6 month after last intervention]

    objective measurement- voice lab analysis, and subjective measurement- Voice Handicap Index questionnaire

  5. voice quality results In the long term [3 years after last intervention]

    objective measurement- voice lab analysis, and subjective measurement- Voice Handicap Index questionnaire

  6. Cure rates in terms of local, regional or distant recurrence events [3 years after last intervention]

    evidence of malignant disease in the larynx, cervical lymph nodes or distant metastases

  7. Overall survival and disease-dependent survival over a period of at least 3 years [3 years after last intervention]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients with pre-operative diagnosis of squamous cell cancer of the vocal cords at an early stage ( Carcinoma in situ or T1-glottic carcinoma).
Exclusion Criteria:
  • Patients who underwent previous significant vocal cords surgical intervention , or irradiation.

  • Contraindications to any endoscopic surgical treatment (general health condition, patient refusal, technical surgical difficulties)

Contacts and Locations

Locations

Site City State Country Postal Code
1 Kapkan medical center Rehovot Israel

Sponsors and Collaborators

  • Kaplan Medical Center

Investigators

  • Principal Investigator: Yonatan Lahav, Dr, Kaplan Medical Center

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Dr Yonatan Lahav, Dr Yonatan Lahav, Kaplan Medical Center
ClinicalTrials.gov Identifier:
NCT02672904
Other Study ID Numbers:
  • 0057-11-KMC-CTIL
First Posted:
Feb 3, 2016
Last Update Posted:
Oct 11, 2016
Last Verified:
Aug 1, 2016
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Keywords provided by Dr Yonatan Lahav, Dr Yonatan Lahav, Kaplan Medical Center
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 11, 2016